ARCHIVES

Banned Investigator Plans To Resume Clinical Trials Role

This article is from The Cancer Letter archive.

Vol. 16 No. 32 | August 10, 1990

Download PDF Visit The Full Archive

Related Articles

Gritz is president-elect of Society for Research on Nicotine and Tobacco.

September 23, 2005

Editorial: A Record-Breaking Year for The Cancer Letter

December 19, 2014

Xeloda + Oxaliplatin Compares To FOLFOX-4 In First Line

January 30, 2009

RFP Available; Program Announcement

April 16, 1993

Francis Collins Nominated For NIH Director Two Days After Final Stem Cell Guidelines Released.

July 10, 2009

Protocol Amendments Required For 98 NCI-Sponsored Trials

October 8, 2010